Evolent Health Inc.
EVH | NYSE
$3.69
$0 (0.00%)
At close: Sep 21, 2026, 4:00 PM ET
$3.69
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:01 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.88B | 2.55B | 1.96B | 1.35B | 907.96M | 924.64M |
Cost of Revenue | 1.59B | 2.19B | 1.5B | 1.04B | 657.55M | 696.58M |
Gross Profit | 284.03M | 367.35M | 460.47M | 316.58M | 250.41M | 228.06M |
Operating Income | -4.44M | -40.49M | -71.21M | 3.64M | -42.41M | -262.85M |
Interest Income | 4.19M | 5.54M | 5.26M | 1.37M | 407K | 2.63M |
Pretax Income | -534.64M | -63.04M | -202.41M | -62.08M | -29.8M | -330.54M |
Net Income | -534.51M | -61.62M | -113.04M | -19.16M | -37.6M | -334.25M |
Selling & General & Admin | 288.47M | 263.05M | 358.11M | 269.27M | 219.5M | 210.41M |
Research & Development | n/a | n/a | n/a | 27M | n/a | n/a |
Other Expenses | n/a | 144.79M | 173.57M | 16.67M | 73.32M | 280.49M |
Operating Expenses | 288.47M | 407.84M | 531.68M | 312.94M | 292.82M | 490.91M |
Interest Expense | 57.47M | 24.72M | 54.21M | 15.57M | 25.43M | 28.33M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -100.14M |
Cost & Expenses | 1.88B | 2.6B | 2.04B | 1.35B | 950.37M | 1.19B |
Income Tax Expense | -126K | -1.41M | -89.37M | -43.38M | 483K | -2.37M |
Shares Outstanding (Basic) | 114.21M | 114.68M | 111.25M | 93.7M | 86.07M | 84.93M |
Shares Outstanding (Diluted) | 114.21M | 114.68M | 111.25M | 93.7M | 86.07M | 84.93M |
EPS (Basic) | -5.07 | -0.81 | -1.28 | -0.20 | -0.36 | -3.94 |
EPS (Diluted) | -5.07 | -0.81 | -1.28 | -0.20 | -0.36 | -3.94 |
EBITDA | -361.31M | 84.85M | -24.79M | 43.75M | 55.66M | -240.74M |
EBIT | -477.16M | -38.31M | -148.2M | -46.51M | -4.38M | -302.22M |
Depreciation & Amortization | 115.85M | 123.17M | 123.42M | 90.25M | 60.04M | 61.48M |
Add to Watchlist
Select watchlists to add or remove EVH